35855-10-8

Basic information

• Product Name: METHYL N-MORPHOLINOACETATE
• Synonyms: N-MORPHOLINOACETIC ACID METHYL ESTER;4-MORPHOLINEACETIC ACID METHYL ESTER;METHYL N-MORPHOLINOACETATE;METHYL MORPHOLINOACETATE;Methyl morpholinoacetate, 99+%;methyl 4-morpholinoacetate;Morpholine-4-acetic acid methyl ester;Morpholinoacetic acid methyl ester
• CAS NO: 35855-10-8
• Molecular Formula: C₇H₁₃NO₃
• Molecular Weight: 159.18
• Product Categories: Aromatic Morpholines;Miscellaneous Reagents
• Mol File: 35855-10-8.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 215.7°Cat760mmHg
• Flash Point: 84.2°C
• Appearance: /
• Density: 1.089g/cm³
• Vapor Pressure: 0.146mmHg at 25°C
• Refractive Index: 1.4575-1.4595
• CAS DataBase Reference: METHYL N-MORPHOLINOACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL N-MORPHOLINOACETATE(35855-10-8)
• EPA Substance Registry System: METHYL N-MORPHOLINOACETATE(35855-10-8)

Safety Data

• Hazard Codes: C
• Statements: 34
• Safety Statements: 45-36/37/39-26
• Hazardous Substances Data: 35855-10-8(Hazardous Substances Data)

Usage

Chemical Properties

Clear Colourless to Yellow Liquid

Uses

Methyl Morpholinoacetate (cas# 35855-10-8) is a compound useful in organic synthesis.

InChI:InChI=1/C7H13NO3/c1-10-7(9)6-8-2-4-11-5-3-8/h2-6H2,1H3/p+1

Upstream product

• 110-91-8 morpholine 
• 96-34-4 methyl chloroacetate 
• 16695-14-0 Malonic acid monomethyl ester 
• 6832-16-2 methyl diazoacetate 
• 91890-09-4 (E)-4-(3-methylbut-1-en-1-yl)morpholine 
• 96-32-2 bromoacetic acid methyl ester 

Downstream Products

• 770-17-2 2-(4-morpholinyl)acetylhydrazine 
• 1449276-94-1 8-amino-2-(3-fluorophenyl)-N-(1-(2-morpholinoacetyl)azetidin-3-yl)-1,7-naphthyridine-5-carboxamide 
• 3235-69-6 morpholin-4-ylacetic acid 
• 358-21-4 perfluorodiethyl ether 
• 382-28-5 2,2,3,3,5,5,6,6-Octafluoro-4-trifluoromethyl-morpholine 
• 130279-34-4 2,2-difluoro-2-(2,2,3,3,5,5,6,6-octafluoromorpholin-4-yl)acetyl fluoride 
• 622-40-2 2-(morpholin-4-yl)ethanol 

Relevant articles and documents

Hetero-aromatic compound and its use in medicine

The invention provides a hetero-aromatic compound or a stereisomer, geometric isomer, tautomer, despinner, nitrogen oxide, hydrate, solvate, metabolite, metabolism precursor and pharmaceutically acceptable salt or prodrug thereof, which is used for treating proliferative diseases. The invention also discloses a pharmaceutical composition containing the compound and an application of the compound or pharmaceutical composition thereof in preparation of a medicine for treating proliferative diseases.

A new strategy for the construction of α-amino acid esters via decarboxylation

A new α-amino acid esters formation reaction has been developed via decarboxylation. The methodology is distinguished by its practical novelty in terms of the readily accessible starting materials, environmentally benign reaction conditions and waste streams, and wide substrate scope.

POSITIVE RESIST COMPOSITION AND PATTERNING PROCESS

A positive resist composition comprises (A) a resin component which becomes soluble in an alkaline developer under the action of an acid and (B) an acid generator. The resin (A) is a polymer comprising recurring units containing a non-leaving hydroxyl group represented by formula (1) wherein R1 is H, methyl or trifluoromethyl, X is a single bond or methylene, m is 1 or 2, and the hydroxyl group attaches to a secondary carbon atom. The composition is improved in resolution when processed by lithography.